Myxedema coma primary prevention

Jump to navigation Jump to search

Myxedema coma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Myxedema coma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT scan

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Myxedema coma primary prevention On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Myxedema coma primary prevention

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Myxedema coma primary prevention

CDC on Myxedema coma primary prevention

Myxedema coma primary prevention in the news

Blogs on Myxedema coma primary prevention

Directions to Hospitals Treating Psoriasis

Risk calculators and risk factors for Myxedema coma primary prevention

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] ; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]

Overview

Primary Prevention

Effective measures for the primary prevention of myxedema coma include regular follow-up care, undergoing regular blood testing in order to adapt hormone replacement therapy and compliant with medications once the diagnosis of hypothyroidism is made. Keeping hypothyroidism under control with optimal treatment using artificial thyroid hormones myxedema coma can be prvented.[1]

References

  1. Tsuboi K, Ueshiba H (2006). "[Myxedema coma]". Nippon Rinsho (in Japanese). Suppl 1: 344–7. PMID 16776161.